References
- Al-Ani B.: Simvastatin inhibits neutrophil degranulation induced by anti-neutrophil cytoplasm auto-antibodies and N-formyl-methionine-leucine-phenylalanine (fMLP) peptide. Saudi Med J 2013, 34, 477–483.
- Al-Rasheed N.M., Al-Rasheed N.M., Hasan I.H., Al-Ajmi H.N., Mohamad R.A., Mahmoud A.M.: Simvastatin ameliorates diabetic cardiomyopathy by attenuating oxidative stress and inflammation in rats. Oxid Med Cell Longev 2017, 10.1155/2017/1092015
- Antons K.A., Williams C.D., Baker S.K., Phillips P.S.: Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 2006, 119, 400–409.
- Black A.E., Hayes R.N., Roth B.D., Woo P., Woolf T.F.: Metabolism and excretion of atorvastatin in rats and dogs. Drug Metab Dispos 2000, 27, 916–992.
- Buhaescu I., Izzedine H.: Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem 2007, 40, 575–584.
- Chang C.C., Chiu P.F., Chen H.L., Chang T.L., Chang Y.J., Huang C.H.: Simvastatin downregulates the expression of hepcidin and erythropoietin in HepG2 cells. Hemodial Int 2013, 17, 116–121.
- Chello M., Anselmi A., Spadaccio C., Patti G., Goffredo C., Di Sciascio G., Covino E.: Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg 2007, 83, 1374–1380.
- Chello M., Patti G., Candura D., Mastrobuoni S., Di Sciascio G., Agro F., Carassiti M., Covino E.: Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006, 34, 660–667.
- Edwards C.J., Hart D.J., Spector T.D.: Oral statin and increased bone mineral density in postmenopausal women. Lancet, 2000, 355, 2218–2219.
- Endres M.: Statins: potential new indications in inflammatory conditions. Atheroscler Suppl 2006, 7, 31–35.
- Fan J., Rone M.B., Papadopoulos V.: Translocator protein 2 is involved in cholesterol redistribution during erythropoiesis J Biol Chem 2009, 284, 30484–30497.
- Fathi H.A., Allam A., Elsabahy M., Fetih G., El-Badry M.: Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin. Colloids Surf B Biointerfaces 2017, 28, 236–245.
- Glińska K., Nicpoń J., Pawlas M.: Mechanism of action statins and possibilities of their application in dog therapy. Med Weter 2006, 62, 254–256.
- Godfrey L.M., Erramouspe J., Cleveland K.W.: Teratogenic risk of statins in pregnancy. Ann Pharmacother 2012, 46, 1419–1424.
- Huang X., Liang Y., Yang Y., Lu X.: Single-step production of the simvastatin precursor monacolin J by engineering of an industrial strain of Aspergillus terreus Metab Eng 2017, 42, 109–114.
- Ii M., Losordo D.W.: Statins and the endothelium. Vasc Pharmacol 2007, 46, 1–9.
- Matsuzawa Y., Kita T., Mabuchi H., Matsuzako M., Nakaya N., Oikawa S., Saito Y., Sasaki J., Shimamoto K., Itakura H.: The J-LIT group: sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effect in 51,321 Japanese hypercholesterolemic patients implication of the J-LIT study, a large scale nationwide cohort study. Circ J 2003, 67, 287–294.
- Mohammadian M., Sadeghipour H.R., Kashani I.R., Jahromi G.P., Omidi A., Nejad A.K., Golchoobian R., Boskabady M.H.: Evaluation of simvastatin and bone marrow-derived mesenchymal stem cell combination therapy on airway remodeling in a mouse asthma model. Lung 2016, 194, 777–785.
- Namazi M.R., Handjani F., Sodaifi M.: The potential utility of statins as novel weapons against graft-versus-host disease. Med Hypotheses 2005, 65, 1203–1204.
- Newman A., Clutterbuck R.D., Powles R.L., Millar J.L.: Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatin. Leukemia 1994, 8, 274–280.
- Nomura T.: Japanese clinical statistical data of patients with aplastic anemia. Nippon Rinsho 1992, 50, 735–746.
- Piorkowski M., Fisher S., Stellbaum C., Jaster M., Martus P., Morguet A.J., Schultheiss H.P., Rauch U.: Treatment with ezetimibe plus low-dose Atorvastatin compared with higher-dose Atorvastatin alone. J Am Coll Cardiol 2007, 48, 1035–1042.
- Pucetti L., Bruni F., Bova G., Cercignani M., Pompella A., Auteri A., Pasqui A.I.: Role of platelets in tissue factor expression by monocytes in normal and hypercholesterolaemia subjects. In vivo effect of cerivastatin. Int J Clin Lab Res 2000, 30, 147–156.
- Shahbazian H., Atrian A., Yazdanpanah L., Lashkarara G.R., Zafar Mohtashami A.: Anti-inflammatory effect of simvastatin in hemodialysis patients. Jundishapur J Nat Pharm Prod 2015, 10, el17962.
- Shimamura M., Urabe A., Takaku F., Mizuno M.: Effects of dolichol and dolichyl phosphate on in vitro differentiation of hematopoietic progenitors. Int J Cell Cloning 1985, 3, 313–319.
- Slawinska A., Kandefer-Szerszen M.: The anticancer properties of statins. Postępy Hig Med Dosw 2008, 62, 393–404.
- Snarska A., Gonkowski S., Rytel L., Pomianowski A., Babińska I., Otrocka-Domagała I., Żarczyńska K., Wysocka D., Sobiech P.: Influence of simvastatin on red blood cell line in porcine bone marrow. Pol J Vet Sci 2017, 4, 811–814.
- Sukpat S., Isrrasena N., Patumraj S.: Pleiotropic effects of simvastatin on wound healing in diabetic mice. J Med Assoc Thai 2016, 99, 213–219.
- Tun T., Kang Y.S.: Effects of simvastatin on CAT-1 mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lined (TR-iBRB). Microvasc Res 2017, 111, 60–66.
- Vilimanovich U., Bosnjak M., Bogdanovic A., Markovic I., Isakovic A., Kravic-Stevovic T., Mircic A., Trajkovic V., Bumbasirevic V.: Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells. Eur J Pharmacol 2015, 15, 415–428.
- Wong M.J., Kantores C., Ivanovska J., Jain A., Jankov R.P.: Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling. Am J Physiol Lung Cell Mol Physiol 2016, 311, 985–999.